Skip to main content
. 2024 Feb 29;16(5):988. doi: 10.3390/cancers16050988

Figure 3.

Figure 3

Figure 3

Overall survival according to codon 61 RAS mutational status. (A) Codon 61 RAS-mutated vs. RAS/BRAF wild-type patients. (B) Codon 61 RAS-mutated vs. non-codon 61 RAS-mutated patients. (C) Codon 61 RAS-mutated vs. BRAF V600E-mutated patients.